About The Gazette Search Back Issues Contact Us    
The newspaper of The Johns Hopkins University October 3, 2005 | Vol. 35 No. 5
Newly Discovered Gene May Predict Aggressive Ovarian Cancer

By Vanessa Wasta
Johns Hopkins Medicine

Johns Hopkins Kimmel Cancer Center researchers have linked alterations in a gene, called Rsf-1, to the most deadly ovarian cancers. The scientists say the discovery is the first to establish a role for the gene in ovarian cancer and may lead to a test that can predict, early on, which patients will develop aggressive disease.

"We hope new therapies can be tailored to target Rsf-1, in the same way that Herceptin for breast cancer attacks the Her2/neu gene pathway," Tian-Li Wang, assistant professor of gynecology/obstetrics and oncology, said.

The scientists' findings, reported in the Sept. 27 issue of Proceedings of the National Academy of Sciences, described a surge in the number of Rsf-1 gene copies in 13.2 percent (16 of 121) of high-grade ovarian cancers but not in low-grade or benign ovarian tumors. Normally, cells contain two copies of every gene. In cancer cells, the copying mechanism goes haywire creating dozens of gene copies in a process called amplification.

Survival data showed that the 16 patients with Rsf-1 amplification fared worse than patients without the ramped-up genes, living an average of 29 months vs. 36 months from date of primary surgery.

Hopkins scientists discovered their first clues to Rsf-1 after sifting through the entire genome of seven ovarian cancer cell lines using a method developed three years ago with their Johns Hopkins colleague Victor Velculescu. The search tool digitizes genetic code and pinpoints abnormalities within precise regions of the DNA, much the way global mapping tools zoom in on specific addresses.

According to Ie-Ming Shih, associate professor of pathology and oncology, who co-directs the laboratory with Wang, other gene-typing methods can identify abnormalities within wide areas of the genome, but the tool used for this study, called digital karyotyping, is far more precise. "It's like narrowing down our search from the entire state of Maryland to a certain building in Baltimore City," he said.

In three of the seven cell lines, the scientists homed in on chromosome 11 after finding high levels of amplification in a region known for cancer-related genes. Further analysis of this region revealed that the Rsf-1 gene was overexpressed far more than 12 other genes in the same area.

Rsf-1 typically opens and closes the scaffolding structure of DNA, which acts as the gatekeeper to protein manufacturing. The Johns Hopkins scientists say that when Rsf-1 is amplified, it may disturb this process and create more space for protein production of certain genes that may promote tumor growth.

"It's important for us to learn more about how Rsf-1 creates aggressive cancers in order to develop drugs that target it," Wang said. "But right now, we'll need to test larger samples to determine if Rsf-1 accurately predicts clinical outcome."

Funding for this research was provided by the U.S. Department of Defense, National Institute of Health, Alexander and Margaret Stewart Trust and Richard TeLinde Endowed Fund.

Other study authors include Jim Jinn-Chyuan Sheu, Antonio Santillan, Kentaro Nakayama, M. Jim Yen, Robert E. Bristow, Russell Vang, Giovanni Parmigiani, Robert J. Kurman, Clas G. Trope and Ben Davidson.


Related Web sites

Johns Hopkins Kimmel Cancer Center
Johns Hopkins Ovarian Cancer Center


The Gazette | The Johns Hopkins University | Suite 540 | 901 S. Bond St. | Baltimore, MD 21231 | 443-287-9900 |